
Today we’re celebrating the work of Mayank Amin, PharmD, RPh, MBA, owner of Skippack Pharmacy.

Today we’re celebrating the work of Mayank Amin, PharmD, RPh, MBA, owner of Skippack Pharmacy.

Pharmacists push against state-level limits on dispensing of hydroxychloroquine for coronavirus disease 2019.

Hospitals can apply at no cost to locate and trade critical supplies to help ease drug shortages during the pandemic.

PBMI informs, advises, and influences the industry on drug cost management.

One of the critical barriers surrounding the coronavirus disease 2019 (COVID-19) pandemic is the lack of access to testing, specifically among high-risk populations.

More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what physicians typically recommend for chronic pain relief via data from clinical studies, according to research published in PLOS ONE.

According to a recent study in the Heart journal, regular tub bathing is linked to a lower risk of death from heart disease and stroke.

Novartis and Rising Pharmaceuticals are donating doses of hydroxychloroquine to be utilized by researchers investigating safety and efficacy against COVID-19.

RedHill Biopharma Ltd today announced that it has completed the recently announced acquisition of the global rights to Movantik (naloxegol) for the treatment of opioid-induced constipation (OIC) from AstraZeneca.

Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.

The Department of Health and Human Services said that there are only 5 locations out of 67,000 pharmacy sites with the capacity to test for COVID-19 through the Community-Based Testing Site program.

Today’s pharmacy hero is Shawn Hodges, PharmD, of Innovation Compounding Pharmacy in Kennesaw, Georgia.

Rural community pharmacies evolve to continue serving low-income patients with chronic conditions during the coronavirus disease 2019 pandemic.

The announcement is in response to ongoing reports of contamination with N-Nitrosodimethylamine (NDMA).

The collaboration will combine VBI’s viral vaccine experience and coronavirus antigens with the NRC’s unique COVID-19 antigens and assay development capabilities.

The FDA has announced that it is accelerating the development of potentially safe and effective life-saving treatments for patients with the coronavirus 2019 disease.

New advances in medical therapy have made it possible for rosacea patients to achieve clear skin.

Key best practices for protecting pharmacy personnel during the COVID-19 pandemic.

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.

Genomic profiles measured through circulating free DNA in the blood of patients with breast cancer may provide a more effective way to treat the disease and track its progression.

Study shows rivaroxaban (Xarelto, Bayer) following nonmajor orthopedic surgery reduced the risk of major venous thromboembolism by approximately 75% compared with enoxaparin.

This group of health care professionals has experienced the burdens associated with increased patient demands, the potential for exposure, and shifting role expectations.

The National Association of Boards of Pharmacy Passport is a temporary authorization that facilitates pharmacists and pharmacy technicians practicing in another state.

Patients with symptomatic peripheral artery disease who took rivaroxaban (Xarelto, Bayer) saw a 15% reduction in the risk of major adverse limb and cardiovascular events.

Pharmacists can play an important role in educating patients about poison prevention tips during the pandemic, and discuss the dangers of home remedies.

Pharmacy Times’ parent company will be hosting the virtual MJH Life Sciences Sleeves Up Blood Drive from March 31 through April 30.

A recent study has detailed information on the potential dangers and the application of QTc monitoring to guide treatment when using drugs that can cause heart rhythm changes.

The length of time patients remained contagious after the end of their symptoms, however, ranged from 1 to 8 days.

"We are trying to stay strong, and we couldn’t cope with this situation if it wasn’t for our deep team connection.”

A study by the American Academy of Neurology suggests that taking a low-dose aspirin once per day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or possible Alzheimer disease.